188 related articles for article (PubMed ID: 25575139)
1. The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity.
Kaur H; Hütt-Cabezas M; Weingart MF; Xu J; Kuwahara Y; Erdreich-Epstein A; Weissman BE; Eberhart CG; Raabe EH
J Neuropathol Exp Neurol; 2015 Feb; 74(2):177-85. PubMed ID: 25575139
[TBL] [Abstract][Full Text] [Related]
2. Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNA.
Zhang K; Gao H; Wu X; Wang J; Zhou W; Sun G; Wang J; Wang Y; Mu B; Kim C; Chu P; Ho DM; Ann DK; Wong TT; Yen Y
Clin Cancer Res; 2014 Mar; 20(5):1179-89. PubMed ID: 24423609
[TBL] [Abstract][Full Text] [Related]
3. The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma.
Kaur H; Ali SZ; Huey L; Hütt-Cabezas M; Taylor I; Mao XG; Weingart M; Chu Q; Rodriguez FJ; Eberhart CG; Raabe EH
Cancer Lett; 2016 Jul; 377(1):55-64. PubMed ID: 27102002
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
Alimova I; Pierce A; Danis E; Donson A; Birks DK; Griesinger A; Foreman NK; Santi M; Soucek L; Venkataraman S; Vibhakar R
Int J Cancer; 2019 Apr; 144(8):1983-1995. PubMed ID: 30230537
[TBL] [Abstract][Full Text] [Related]
5. Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target.
Weingart MF; Roth JJ; Hutt-Cabezas M; Busse TM; Kaur H; Price A; Maynard R; Rubens J; Taylor I; Mao XG; Xu J; Kuwahara Y; Allen SJ; Erdreich-Epstein A; Weissman BE; Orr BA; Eberhart CG; Biegel JA; Raabe EH
Oncotarget; 2015 Feb; 6(5):3165-77. PubMed ID: 25638158
[TBL] [Abstract][Full Text] [Related]
6. HMGA2 gene is a promising target for ovarian cancer silencing therapy.
Malek A; Bakhidze E; Noske A; Sers C; Aigner A; Schäfer R; Tchernitsa O
Int J Cancer; 2008 Jul; 123(2):348-356. PubMed ID: 18452175
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
8. [Selection and anti-cancer effects of siRNAs targeting HMGA2 gene].
Wang QZ; Gong YH; Lü YH; Fei LN; Liu HJ; Diao Y; Xu RA
Yao Xue Xue Bao; 2011 Dec; 46(12):1444-50. PubMed ID: 22375416
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-490-3p regulates cell proliferation and apoptosis by targeting HMGA2 in osteosarcoma.
Liu W; Xu G; Liu H; Li T
FEBS Lett; 2015 Oct; 589(20 Pt B):3148-53. PubMed ID: 26341146
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors.
Studebaker AW; Hutzen B; Pierson CR; Shaffer TA; Raffel C; Jackson EM
Neuro Oncol; 2015 Dec; 17(12):1568-77. PubMed ID: 25838138
[TBL] [Abstract][Full Text] [Related]
11. The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity.
Rubens JA; Wang SZ; Price A; Weingart MF; Allen SJ; Orr BA; Eberhart CG; Raabe EH
Neuro Oncol; 2017 Oct; 19(10):1361-1371. PubMed ID: 28582547
[TBL] [Abstract][Full Text] [Related]
12. Silencing of HMGA2 promotes apoptosis and inhibits migration and invasion of prostate cancer cells.
Shi Z; Wu D; Tang R; Li X; Chen R; Xue S; Zhang C; Sun X
J Biosci; 2016 Jun; 41(2):229-36. PubMed ID: 27240983
[TBL] [Abstract][Full Text] [Related]
13. Targeting of high mobility group A2 by small interfering RNA-loaded nanoliposome-induced apoptosis and migration inhibition in gastrointestinal cancer cells.
Mohammadi A; Mansoori B; Savadi P; Khaze V; Minouei M; McMillan NAJ; Hallaj-Nezhadi S; Baradaran B
J Cell Biochem; 2019 Jun; 120(6):9203-9212. PubMed ID: 30507008
[TBL] [Abstract][Full Text] [Related]
14. MEK Inhibition Suppresses Growth of Atypical Teratoid/Rhabdoid Tumors.
Shahab S; Rubens J; Kaur H; Sweeney H; Eberhart CG; Raabe EH
J Neuropathol Exp Neurol; 2020 Jul; 79(7):746-753. PubMed ID: 32472116
[TBL] [Abstract][Full Text] [Related]
15. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
[TBL] [Abstract][Full Text] [Related]
16. Elevated HMGA2 expression is associated with cancer aggressiveness and predicts poor outcome in breast cancer.
Wu J; Zhang S; Shan J; Hu Z; Liu X; Chen L; Ren X; Yao L; Sheng H; Li L; Ann D; Yen Y; Wang J; Wang X
Cancer Lett; 2016 Jul; 376(2):284-92. PubMed ID: 27063096
[TBL] [Abstract][Full Text] [Related]
17. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
[TBL] [Abstract][Full Text] [Related]
18. [The effects of lentivirus-mediated RNA interference silencing HMGA2 on proliferation and expressions of cyclin B2 and cyclin A2 in HL-60 cells].
Liu WD; Tan L; Xiong XF; Liang YP; Tan H
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):448-52. PubMed ID: 22967378
[TBL] [Abstract][Full Text] [Related]
19. Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine.
Wang SZ; Poore B; Alt J; Price A; Allen SJ; Hanaford AR; Kaur H; Orr BA; Slusher BS; Eberhart CG; Raabe EH; Rubens JA
Clin Cancer Res; 2019 Oct; 25(19):5925-5936. PubMed ID: 31300448
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines.
Di Fazio P; Montalbano R; Neureiter D; Alinger B; Schmidt A; Merkel AL; Quint K; Ocker M
Exp Cell Res; 2012 Sep; 318(15):1832-43. PubMed ID: 22683924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
